Displaying 61 to 80 of 104 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Nellix Endovascular Inc |
United States | 13 Dec 2010 | N/A |
|
|
|
NeoVista Inc |
United States | 1 Feb 2011 | Series E Follow-on investment. Round participant. Active |
|
|
|
NeoVista Inc |
United States | 1 Dec 2006 | Series C Initial investment. Round participant. Active |
|
|
|
NeoVista Inc |
United States | 1 Mar 2009 | Series D Follow-on investment. Round participant. Active |
|
|
|
Novacept Inc Commercializing innovative medical devices to improve the quality and cost-effectiveness of healthcare for women. |
United States | N/A |
||
|
|
Open Monoclonal Technology Inc Builds the first platform for generating human monoclonal antibodies using a transgenic rat. |
United States | N/A |
||
|
|
Oraya Therapeutics Inc Developing a radiation-based treatment for wet AMD |
United States | 1 Jan 2008 | Series B |
|
|
|
Oraya Therapeutics Inc Developing a radiation-based treatment for wet AMD |
United States | 1 Jul 2009 | Series C |
|
|
|
Oraya Therapeutics Inc Developing a radiation-based treatment for wet AMD |
United States | 1 Jun 2007 | Series A |
|
|
|
Orthovita Inc Orthopedic surgical biomaterials company offering advanced bone regeneration and soft tissue healing technologies |
United States | N/A |
||
|
|
Palatin Technologies Inc Develops peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems |
United States | N/A |
||
|
|
Palmetto Pharmaceuticals Inc Develops products which improve and restore blood flow |
United States | N/A |
||
|
|
PAREXEL PAREXEL is a public Core Company formed as a global, full service Contract Research Organization (CRO). |
United States | N/A |
||
|
|
PreCision Dermatology Inc Develops, manufactures, acquires and markets dermatology products |
United States | N/A |
||
|
|
Prism Pharmaceuticals Inc Develops and commercializes branded cardiovascular injectable products |
United States | N/A |
||
|
|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Oct 2010 | Series F |
||
|
|
Proteus Biomedical Inc Cardiac diagnostic devices |
United States | 1 Oct 2008 | Series D |
|
|
|
QSpex Technologies Inc Develops the Lens Transformation Technology to allow eye care specialists to produce high quality, premium ophthalmic lenses. |
United States | N/A |
||
|
|
Repros Therapeutics Inc Focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders |
United States | N/A |
||
|
|
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jun 2011 | Venture |